Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
On Oct. 16, 2026, NGVT is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5184 stocks scored that day.
Ingevity Corp is a mid-cap company with a market capitalization of $2.40B. It ranks number 3 by market capitalization among the 17 Chemicals & Allied Products issuers in our coverage with a current forecast. Its P/B Ratio of 51.18x is the highest of the 12 peers that report one. Its ROE of 115.1% is the highest of the 10 peers that report one.
For NGVT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NGVT included.
Follow NGVT free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
| Metric | NGVT | Rank |
|---|---|---|
| Market Cap | $2.40B | 3/17 |
| P/E Ratio | 33.73x | – |
| P/B Ratio | 51.18x | 1/12 |
| EPS | $2.07 | – |
| Book Value/Share | $1.36 | – |
| Revenue/Share | $31.72 | – |
| FCF/Share | $4.51 | – |
| Metric | NGVT | Rank |
|---|---|---|
| ROE | 115.1% | 1/10 |
| ROA | 3.5% | 3/13 |
| ROIC | 59.2% | 1/12 |
| Gross Margin | 42.7% | 4/14 |
| Operating Margin | 65.2% | 1/13 |
| Net Margin | 5.0% | 3/12 |
| EBT Margin | 5.0% | 4/14 |
| Tax Rate | 28.9% | – |
| Metric | NGVT | Rank |
|---|---|---|
| Current Ratio | 1.61x | 11/16 |
| Quick Ratio | 1.15x | 8/13 |
| D/E Ratio | 31.78x | 1/13 |
| Financial Leverage | 32.78x | 1/14 |
| Interest Coverage | 15.2x | 3/14 |
| Working Capital | $206M | 7/16 |
| Metric | NGVT | Rank |
|---|---|---|
| Operating Cash Flow | $211M | 5/15 |
| Free Cash Flow | $155M | 2/9 |
| Capital Spending | -$56M | 4/9 |
| OCF Growth YoY | -2.0% | 5/8 |
| FCF Growth YoY | 3.1% | 3/5 |
| FCF/Sales | 14.2% | 1/9 |
| CapEx/Sales | 5.1% | 3/9 |
| Metric | NGVT | Rank |
|---|---|---|
| Asset Turnover | 0.71x | 5/13 |
| Inventory Turnover | 4.1x | 8/13 |
| Fixed Assets Turnover | 1.9x | 10/13 |
| Days Inventory | 90 days | 6/13 |
| Payables Period | 51 days | 8/10 |
| Metric | NGVT | Rank |
|---|---|---|
| Total Revenue | $1.09B | 6/13 |
| Operating Income | $711M | 1/14 |
| Net Income | $54M | 3/13 |
| R&D Expense | $26M | 5/10 |
| SG&A Expense | $164M | 6/13 |
| Cost of Goods Sold | $625M | 8/14 |
| Metric | NGVT | Rank |
|---|---|---|
| Shares Outstanding | 34M | – |
| Total Current Assets | $544M | 35.4% of assets |
| Cash & Short-term Investments | $97M | 6.3% of assets |
| Inventory | $154M | 10.0% of assets |
| Total Liabilities | $1.49B | 96.9% of assets |
| Short-term Debt | $250M | 16.2% of assets |
Companies classified under the same SEC industry code as Ingevity Corp (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| NGVT Ingevity Corp | ▶ | $2.40B |
| BCPC Balchem Corp | ▼ | $5.44B |
| PRM Perimeter Solutions, Inc. | ▶ | $4.34B |
| IOSP Innospec Inc. | ▼ | $2.38B |
| CC Chemours Co | ▶ | $1.92B |
| OLN Olin Corp | ▼ | $1.78B |
| HUN Huntsman Corp | ▼ | $1.49B |
| ECVT Ecovyst Inc. | ▶ | $1.13B |
| FMC Fmc Corp | ▲ | $709M |
| SLI Standard Lithium Ltd. | ▲ | $359M |
| ADUR Aduro Clean Technologies Inc. | ▼ | $330M |
| ACNT Ascent Industries Co. | ▼ | $122M |
| LQMT Liquidmetal Technologies Inc | ▶ | $71M |
| CITR Citrotech Inc. | ▶ | $62M |
| BLGO Biolargo, Inc. | ▲ | $23M |
| LOOP Loop Industries, Inc. | ▶ | $16M |
| GURE Gulf Resources, Inc. | ▲ | $6M |
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
In Ingevity Corp. v. BASF Corp., the Federal Circuit affirmed a jury verdict finding that Ingevity Corp. (Ingevity) violated antitrust laws by tying licenses to its fuel‑vapor canister patent to ...
On Oct. 16, 2026, NGVT is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5184 stocks scored that day.
For NGVT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Ingevity Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
17 issuers in our coverage, NGVT included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Solutions, Inc. (PRM), Innospec Inc. (IOSP), Chemours Co (CC), Olin Corp (OLN), Huntsman Corp (HUN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.